Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease (COPD)

26. juni 2014 oppdatert av: Boehringer Ingelheim

Drug Use Results Survey of Tiotropium Bromide

To collect post-marketing safety and effectiveness information on the use of Tiotropium Inhalation Capsules (18 μg) in patients with chronic obstructive pulmonary disease in daily clinical settings

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Observasjonsmessig

Registrering (Faktiske)

3588

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Japan
      • Abashiri, Japan
        • Boehringer Ingelheim Investigational Site
      • Aizubangemachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Aizumisatomachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Aizuwakamatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Akashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Akita, Japan
        • Boehringer Ingelheim Investigational Site
      • Ako, Japan
        • Boehringer Ingelheim Investigational Site
      • Amagasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Amakusa, Japan
        • Boehringer Ingelheim Investigational Site
      • Amimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Anan, Japan
        • Boehringer Ingelheim Investigational Site
      • Anjo, Japan
        • Boehringer Ingelheim Investigational Site
      • Arakawamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Arao, Japan
        • Boehringer Ingelheim Investigational Site
      • Aritacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Asahikawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Ashikaga, Japan
        • Boehringer Ingelheim Investigational Site
      • Atami, Japan
        • Boehringer Ingelheim Investigational Site
      • Atsugi, Japan
        • Boehringer Ingelheim Investigational Site
      • Awa, Japan
        • Boehringer Ingelheim Investigational Site
      • Ayabe, Japan
        • Boehringer Ingelheim Investigational Site
      • Ayagawacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Ayase, Japan
        • Boehringer Ingelheim Investigational Site
      • Beppu, Japan
        • Boehringer Ingelheim Investigational Site
      • Bibai, Japan
        • Boehringer Ingelheim Investigational Site
      • Bungoohno, Japan
        • Boehringer Ingelheim Investigational Site
      • Chiba, Japan
        • Boehringer Ingelheim Investigational Site
      • Chigasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Chikusei, Japan
        • Boehringer Ingelheim Investigational Site
      • Chikushino, Japan
        • Boehringer Ingelheim Investigational Site
      • Chitose, Japan
        • Boehringer Ingelheim Investigational Site
      • Date, Japan
        • Boehringer Ingelheim Investigational Site
      • Ebetsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Echizen, Japan
        • Boehringer Ingelheim Investigational Site
      • Emukaecho, Japan
        • Boehringer Ingelheim Investigational Site
      • Engarucho, Japan
        • Boehringer Ingelheim Investigational Site
      • Fuchuu, Japan
        • Boehringer Ingelheim Investigational Site
      • Fuji, Japan
        • Boehringer Ingelheim Investigational Site
      • Fujiidera, Japan
        • Boehringer Ingelheim Investigational Site
      • Fujikawaguchiko, Japan
        • Boehringer Ingelheim Investigational Site
      • Fujinomiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukaya, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukuchiyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukui, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukuoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukuroi, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukushima, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukutsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Fukuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Funabashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Futabamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Geiseimura, Japan
        • Boehringer Ingelheim Investigational Site
      • Gifu, Japan
        • Boehringer Ingelheim Investigational Site
      • Ginowan, Japan
        • Boehringer Ingelheim Investigational Site
      • Gobo, Japan
        • Boehringer Ingelheim Investigational Site
      • Gosen, Japan
        • Boehringer Ingelheim Investigational Site
      • Gotenba, Japan
        • Boehringer Ingelheim Investigational Site
      • Gyouda, Japan
        • Boehringer Ingelheim Investigational Site
      • Habikino, Japan
        • Boehringer Ingelheim Investigational Site
      • Hachinohe, Japan
        • Boehringer Ingelheim Investigational Site
      • Hachirogatamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hagi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hakodate, Japan
        • Boehringer Ingelheim Investigational Site
      • Hakusan, Japan
        • Boehringer Ingelheim Investigational Site
      • Hamada, Japan
        • Boehringer Ingelheim Investigational Site
      • Hamamatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Handa, Japan
        • Boehringer Ingelheim Investigational Site
      • Hanyuu, Japan
        • Boehringer Ingelheim Investigational Site
      • Hatsukaichi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hayashimacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Higashihiroshima, Japan
        • Boehringer Ingelheim Investigational Site
      • Higashimatsushima, Japan
        • Boehringer Ingelheim Investigational Site
      • Higashiomi, Japan
        • Boehringer Ingelheim Investigational Site
      • Higashiosaka, Japan
        • Boehringer Ingelheim Investigational Site
      • Hikari, Japan
        • Boehringer Ingelheim Investigational Site
      • Himeji, Japan
        • Boehringer Ingelheim Investigational Site
      • Hirakata, Japan
        • Boehringer Ingelheim Investigational Site
      • Hiratsuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Hirosaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Hiroshima, Japan
        • Boehringer Ingelheim Investigational Site
      • Hita, Japan
        • Boehringer Ingelheim Investigational Site
      • Hitachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hitoyoshi, Japan
        • Boehringer Ingelheim Investigational Site
      • Hofu, Japan
        • Boehringer Ingelheim Investigational Site
      • Iamabari, Japan
        • Boehringer Ingelheim Investigational Site
      • Ibaraki, Japan
        • Boehringer Ingelheim Investigational Site
      • Ibarakimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Ibigawacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Ibusuki, Japan
        • Boehringer Ingelheim Investigational Site
      • Ichihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Ichinomiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Ichinoseki, Japan
        • Boehringer Ingelheim Investigational Site
      • Iga, Japan
        • Boehringer Ingelheim Investigational Site
      • Iida, Japan
        • Boehringer Ingelheim Investigational Site
      • Iizuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Ikoma, Japan
        • Boehringer Ingelheim Investigational Site
      • Imari, Japan
        • Boehringer Ingelheim Investigational Site
      • Imizu, Japan
        • Boehringer Ingelheim Investigational Site
      • Ina, Japan
        • Boehringer Ingelheim Investigational Site
      • Inazawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Inuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Isahaya, Japan
        • Boehringer Ingelheim Investigational Site
      • Ise, Japan
        • Boehringer Ingelheim Investigational Site
      • Isehara, Japan
        • Boehringer Ingelheim Investigational Site
      • Ishikari, Japan
        • Boehringer Ingelheim Investigational Site
      • Ishinomaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Itami, Japan
        • Boehringer Ingelheim Investigational Site
      • Itanocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Ito, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwakuni, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwamizawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwanaicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Iwata, Japan
        • Boehringer Ingelheim Investigational Site
      • Iyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Izu, Japan
        • Boehringer Ingelheim Investigational Site
      • Izumisano, Japan
        • Boehringer Ingelheim Investigational Site
      • Izumo, Japan
        • Boehringer Ingelheim Investigational Site
      • Izunokuni, Japan
        • Boehringer Ingelheim Investigational Site
      • Jimokujicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Joso, Japan
        • Boehringer Ingelheim Investigational Site
      • Jouetsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Joyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Kaga, Japan
        • Boehringer Ingelheim Investigational Site
      • Kagoshima, Japan
        • Boehringer Ingelheim Investigational Site
      • Kaizuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Kajikicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Kakegawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Kami, Japan
        • Boehringer Ingelheim Investigational Site
      • Kamiamakusa, Japan
        • Boehringer Ingelheim Investigational Site
      • Kamisu, Japan
        • Boehringer Ingelheim Investigational Site
      • Kanazawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Kandamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kanonji, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasai, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasama, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasaoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Kashihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Kashima, Japan
        • Boehringer Ingelheim Investigational Site
      • Kashiwazaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasuga, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasuigai, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasukabe, Japan
        • Boehringer Ingelheim Investigational Site
      • Kasuyamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kato, Japan
        • Boehringer Ingelheim Investigational Site
      • Katsuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawachinagano, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawagoe, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawaguchi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawanishimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kawasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Kayano, Japan
        • Boehringer Ingelheim Investigational Site
      • Kazuno, Japan
        • Boehringer Ingelheim Investigational Site
      • Kinkocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Kitakami, Japan
        • Boehringer Ingelheim Investigational Site
      • Kitakyushu, Japan
        • Boehringer Ingelheim Investigational Site
      • Kitami, Japan
        • Boehringer Ingelheim Investigational Site
      • Kobe, Japan
        • Boehringer Ingelheim Investigational Site
      • Kochi, Japan
        • Boehringer Ingelheim Investigational Site
      • Koga, Japan
        • Boehringer Ingelheim Investigational Site
      • Komonocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Konan, Japan
        • Boehringer Ingelheim Investigational Site
      • Koriyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Kouriyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Koushi, Japan
        • Boehringer Ingelheim Investigational Site
      • Koushu, Japan
        • Boehringer Ingelheim Investigational Site
      • Kozakaicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Kudamatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Kumamoto, Japan
        • Boehringer Ingelheim Investigational Site
      • Kunimimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kunisaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Kurashiki, Japan
        • Boehringer Ingelheim Investigational Site
      • Kurayoshi, Japan
        • Boehringer Ingelheim Investigational Site
      • Kure, Japan
        • Boehringer Ingelheim Investigational Site
      • Kurihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Kurume, Japan
        • Boehringer Ingelheim Investigational Site
      • Kushiro, Japan
        • Boehringer Ingelheim Investigational Site
      • Kuwana, Japan
        • Boehringer Ingelheim Investigational Site
      • Kyotango, Japan
        • Boehringer Ingelheim Investigational Site
      • Kyoto, Japan
        • Boehringer Ingelheim Investigational Site
      • Maebashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Marugame, Japan
        • Boehringer Ingelheim Investigational Site
      • Masuda, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsudo, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsue, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsumoto, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsusaka, Japan
        • Boehringer Ingelheim Investigational Site
      • Matsuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Mibumachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Mihamacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Mihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Minamisatsuma, Japan
        • Boehringer Ingelheim Investigational Site
      • Minamisouma, Japan
        • Boehringer Ingelheim Investigational Site
      • Minamiuonuma, Japan
        • Boehringer Ingelheim Investigational Site
      • Mino, Japan
        • Boehringer Ingelheim Investigational Site
      • Minoh, Japan
        • Boehringer Ingelheim Investigational Site
      • Misasacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Misato, Japan
        • Boehringer Ingelheim Investigational Site
      • Mishima, Japan
        • Boehringer Ingelheim Investigational Site
      • Mito, Japan
        • Boehringer Ingelheim Investigational Site
      • Miyakicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Miyakonojo, Japan
        • Boehringer Ingelheim Investigational Site
      • Miyazaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Miyoshi, Japan
        • Boehringer Ingelheim Investigational Site
      • Mizunami, Japan
        • Boehringer Ingelheim Investigational Site
      • Mobara, Japan
        • Boehringer Ingelheim Investigational Site
      • Moriguchi, Japan
        • Boehringer Ingelheim Investigational Site
      • Morioka, Japan
        • Boehringer Ingelheim Investigational Site
      • Muroran, Japan
        • Boehringer Ingelheim Investigational Site
      • Nabari, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagahama, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagano, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagaoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagato, Japan
        • Boehringer Ingelheim Investigational Site
      • Nago, Japan
        • Boehringer Ingelheim Investigational Site
      • Nagoya, Japan
        • Boehringer Ingelheim Investigational Site
      • Naha, Japan
        • Boehringer Ingelheim Investigational Site
      • Nakama, Japan
        • Boehringer Ingelheim Investigational Site
      • Nakashibetsucho, Japan
        • Boehringer Ingelheim Investigational Site
      • Nanao, Japan
        • Boehringer Ingelheim Investigational Site
      • Nankoku, Japan
        • Boehringer Ingelheim Investigational Site
      • Nantan, Japan
        • Boehringer Ingelheim Investigational Site
      • Nara, Japan
        • Boehringer Ingelheim Investigational Site
      • Naruto, Japan
        • Boehringer Ingelheim Investigational Site
      • Nasukarasuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Neyagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Nihonmatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Niigata, Japan
        • Boehringer Ingelheim Investigational Site
      • Niihamashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Nikko, Japan
        • Boehringer Ingelheim Investigational Site
      • Nishiiyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Nishinomiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Nishio, Japan
        • Boehringer Ingelheim Investigational Site
      • Nobeoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Noboribetsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Noda, Japan
        • Boehringer Ingelheim Investigational Site
      • Nomi, Japan
        • Boehringer Ingelheim Investigational Site
      • Noshiro, Japan
        • Boehringer Ingelheim Investigational Site
      • Notocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Numata, Japan
        • Boehringer Ingelheim Investigational Site
      • Numazu, Japan
        • Boehringer Ingelheim Investigational Site
      • Oaraimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Obama, Japan
        • Boehringer Ingelheim Investigational Site
      • Obihiro, Japan
        • Boehringer Ingelheim Investigational Site
      • Odate, Japan
        • Boehringer Ingelheim Investigational Site
      • Odawara, Japan
        • Boehringer Ingelheim Investigational Site
      • Ogawaramachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Ogi, Japan
        • Boehringer Ingelheim Investigational Site
      • Oita, Japan
        • Boehringer Ingelheim Investigational Site
      • Ojiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Okayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Okinawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Omihachiman, Japan
        • Boehringer Ingelheim Investigational Site
      • Omuta, Japan
        • Boehringer Ingelheim Investigational Site
      • Onomachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Osaka, Japan
        • Boehringer Ingelheim Investigational Site
      • Osakasayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Ota, Japan
        • Boehringer Ingelheim Investigational Site
      • Otake, Japan
        • Boehringer Ingelheim Investigational Site
      • Otaru, Japan
        • Boehringer Ingelheim Investigational Site
      • Otsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Otsumachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Owariasahi, Japan
        • Boehringer Ingelheim Investigational Site
      • Ritto, Japan
        • Boehringer Ingelheim Investigational Site
      • Ryugasaki, Japan
        • Boehringer Ingelheim Investigational Site
      • Sado, Japan
        • Boehringer Ingelheim Investigational Site
      • Saga, Japan
        • Boehringer Ingelheim Investigational Site
      • Sagamihara, Japan
        • Boehringer Ingelheim Investigational Site
      • Saiki, Japan
        • Boehringer Ingelheim Investigational Site
      • Saitama, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakai, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakaimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakaiminato, Japan
        • Boehringer Ingelheim Investigational Site
      • Sakata, Japan
        • Boehringer Ingelheim Investigational Site
      • Saku, Japan
        • Boehringer Ingelheim Investigational Site
      • Sanjyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Sanuki, Japan
        • Boehringer Ingelheim Investigational Site
      • Sanyoonoda, Japan
        • Boehringer Ingelheim Investigational Site
      • Sapporo, Japan
        • Boehringer Ingelheim Investigational Site
      • Sasayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Sasebo, Japan
        • Boehringer Ingelheim Investigational Site
      • Satsumasendai, Japan
        • Boehringer Ingelheim Investigational Site
      • Sayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Sendai, Japan
        • Boehringer Ingelheim Investigational Site
      • Sennan, Japan
        • Boehringer Ingelheim Investigational Site
      • Shibetsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Shibukawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Shimada, Japan
        • Boehringer Ingelheim Investigational Site
      • Shimonoseki, Japan
        • Boehringer Ingelheim Investigational Site
      • Shimotsuke, Japan
        • Boehringer Ingelheim Investigational Site
      • Shimotsuma, Japan
        • Boehringer Ingelheim Investigational Site
      • Shingu, Japan
        • Boehringer Ingelheim Investigational Site
      • Shiogama, Japan
        • Boehringer Ingelheim Investigational Site
      • Shirahamacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Shiroishi, Japan
        • Boehringer Ingelheim Investigational Site
      • Shiroishicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Shizuoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Shoocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Shunan, Japan
        • Boehringer Ingelheim Investigational Site
      • Soo, Japan
        • Boehringer Ingelheim Investigational Site
      • Souka, Japan
        • Boehringer Ingelheim Investigational Site
      • Suita, Japan
        • Boehringer Ingelheim Investigational Site
      • Sukagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Sukumo, Japan
        • Boehringer Ingelheim Investigational Site
      • Sunagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Susono, Japan
        • Boehringer Ingelheim Investigational Site
      • Suwa, Japan
        • Boehringer Ingelheim Investigational Site
      • Suzuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Tagawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Tainai, Japan
        • Boehringer Ingelheim Investigational Site
      • Takahashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Takamatsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Takaoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Takarazuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Takasago, Japan
        • Boehringer Ingelheim Investigational Site
      • Takashima, Japan
        • Boehringer Ingelheim Investigational Site
      • Takatsuki, Japan
        • Boehringer Ingelheim Investigational Site
      • Taku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tamana, Japan
        • Boehringer Ingelheim Investigational Site
      • Tamano, Japan
        • Boehringer Ingelheim Investigational Site
      • Tanabe, Japan
        • Boehringer Ingelheim Investigational Site
      • Taragimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Tenri, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokaimura, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokorozawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokunoshimacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokushima, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Adachi-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Akishima, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Bunkyo-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Chiyoda-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Edogawa-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Hachioji, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Higashimurayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Higashiyamato, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Hino, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Itabashi-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Katsushika-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Kiyose, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Komae, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Koto-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Meguro-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Minato-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Nakano-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Nerima-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Nishitokyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Ome, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Ota-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Setagaya-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Shibuya-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Shinagawa-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Shinjuku-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Suginami-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Sumida-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Taito-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tokyo Toshima-ku, Japan
        • Boehringer Ingelheim Investigational Site
      • Tomakomai, Japan
        • Boehringer Ingelheim Investigational Site
      • Tomigusu, Japan
        • Boehringer Ingelheim Investigational Site
      • Tomioka, Japan
        • Boehringer Ingelheim Investigational Site
      • Tondabayashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Toride, Japan
        • Boehringer Ingelheim Investigational Site
      • Tottori, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyohashi, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyokawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyooka, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyosatocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Toyota, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsu, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsukuba, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsurugicho, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsuruoka, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsushima, Japan
        • Boehringer Ingelheim Investigational Site
      • Tsuyama, Japan
        • Boehringer Ingelheim Investigational Site
      • Ube, Japan
        • Boehringer Ingelheim Investigational Site
      • Uchikocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Uchinadamachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Uekimachi, Japan
        • Boehringer Ingelheim Investigational Site
      • Uji, Japan
        • Boehringer Ingelheim Investigational Site
      • Uki, Japan
        • Boehringer Ingelheim Investigational Site
      • Unzen, Japan
        • Boehringer Ingelheim Investigational Site
      • Urakawacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Urasoe, Japan
        • Boehringer Ingelheim Investigational Site
      • Urayasu, Japan
        • Boehringer Ingelheim Investigational Site
      • Uruma, Japan
        • Boehringer Ingelheim Investigational Site
      • Usa, Japan
        • Boehringer Ingelheim Investigational Site
      • Usuki, Japan
        • Boehringer Ingelheim Investigational Site
      • Utsunomiya, Japan
        • Boehringer Ingelheim Investigational Site
      • Wakayama, Japan
        • Boehringer Ingelheim Investigational Site
      • Yabu, Japan
        • Boehringer Ingelheim Investigational Site
      • Yachimata, Japan
        • Boehringer Ingelheim Investigational Site
      • Yachiyo, Japan
        • Boehringer Ingelheim Investigational Site
      • Yaizu, Japan
        • Boehringer Ingelheim Investigational Site
      • Yakumocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yakushimacho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yamaga, Japan
        • Boehringer Ingelheim Investigational Site
      • Yamagata, Japan
        • Boehringer Ingelheim Investigational Site
      • Yamato, Japan
        • Boehringer Ingelheim Investigational Site
      • Yamatotakada, Japan
        • Boehringer Ingelheim Investigational Site
      • Yanai, Japan
        • Boehringer Ingelheim Investigational Site
      • Yao, Japan
        • Boehringer Ingelheim Investigational Site
      • Yatomi, Japan
        • Boehringer Ingelheim Investigational Site
      • Yatsushiro, Japan
        • Boehringer Ingelheim Investigational Site
      • Yawata, Japan
        • Boehringer Ingelheim Investigational Site
      • Yokkaichi, Japan
        • Boehringer Ingelheim Investigational Site
      • Yokohama, Japan
        • Boehringer Ingelheim Investigational Site
      • Yokosuka, Japan
        • Boehringer Ingelheim Investigational Site
      • Yokote, Japan
        • Boehringer Ingelheim Investigational Site
      • Yonabarucho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yonezawa, Japan
        • Boehringer Ingelheim Investigational Site
      • Yorocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yoshinocho, Japan
        • Boehringer Ingelheim Investigational Site
      • Yufu, Japan
        • Boehringer Ingelheim Investigational Site
      • Yurihonjou, Japan
        • Boehringer Ingelheim Investigational Site

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

COPD patients in daily clinical settings.

Beskrivelse

Inclusion Criteria:

- Patients with COPD

Exclusion Criteria:

-There is no exclusion criterion, because this post marketing study (PMS) is observational survey under condition of normal clinical practice

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Pasienter med KOLS
Legemiddel: Spiriva (tiotropium bromide) inhalation capsules
Survey of patients with COPD using Spiriva (tiotropium bromide) inhalation capsules

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Number of patients with adverse events
Tidsramme: Up to 4 weeks after start of treatment
Up to 4 weeks after start of treatment
Number of patients with adverse drug reactions
Tidsramme: Up to 4 weeks after start of treatment
Up to 4 weeks after start of treatment
Number of patients with serious adverse events
Tidsramme: Up to 4 weeks after start of treatment
Up to 4 weeks after start of treatment

Sekundære resultatmål

Resultatmål
Tidsramme
Physician's overall judgement by medical interview into four grades: 1. Improved 2. No Change 3. Aggravated 4.Unassessable
Tidsramme: Up to 4 weeks after start of treatment
Up to 4 weeks after start of treatment

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Boehringer Ingelheim

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. april 2005

Primær fullføring (Faktiske)

1. september 2007

Datoer for studieregistrering

Først innsendt

31. januar 2008

Først innsendt som oppfylte QC-kriteriene

26. juni 2014

Først lagt ut (Anslag)

27. juni 2014

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

27. juni 2014

Siste oppdatering sendt inn som oppfylte QC-kriteriene

26. juni 2014

Sist bekreftet

1. juni 2014

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 205.314

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere